Jointechlabs, Inc., founded in 2014, is establishing itself as a leader in Biotechnology, Health Care, and Medical Devices with a robust focus on regenerative medicine solutions. The company's slogan, "Regenerative Medicine Solutions", succinctly reflects its core mission to provide cutting-edge, non-surgical therapies.
With the FDA cleared MiniTC® and the CE Mark pending Mini-Stem System™, Jointechlabs offers healthcare practitioners and hospitals innovative devices that fit seamlessly into existing infrastructures, promoting safe and cost-effective treatments. Both platforms further pave the way for advanced development in clinical therapies and 3D Bioprinting of tissues.
The company, headquartered in the United States, secured a $500.00K seed round investment on 07 October 2022 from Newchip Accelerator. This reflects investor confidence in Jointechlabs' potential to drive advancements in the regenerative medicine market.